Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[A Patient with Acute Limbic Encephalitis Associated with Anti-Glutamate Receptor Antibodies and Subsequent Optic Neuritis].
Serial electrophysiological findings in Guillain-Barré syndrome not fulfilling AIDP or AMAN criteria.
Kv1.3 Deletion Biases T Cells toward an Immunoregulatory Phenotype and Renders Mice Resistant to Autoimmune Encephalomyelitis.
Optical Coherence Tomography Detection of Neurodegeneration in Multiple Sclerosis.
Home-based exercise program and fall-risk reduction in older adults with multiple sclerosis: phase 1 randomized controlled trial.
Multiple Sclerosis Disease Progression and Paradichlorobenzene: A Tale of Mothballs and Toilet Cleaner.
Tumor necrosis factor beta (TNF-β) NcoI polymorphism is associated with multiple sclerosis in Caucasian patients from Southern Brazil independently from HLA-DRB1.
Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs.
Effectiveness of Energy-Conservation treatment in reducing fatigue in Multiple Sclerosis: a systematic review and meta-analysis.
Assessment and classification of early stage multiple sclerosis with inertial sensors: comparison against clinical measures of disease state.
Reduced R2' in multiple sclerosis normal appearing white matter and lesions may reflect decreased myelin and iron content.
Expanding the Clinical Indications for Alpha-1-Antitrypsin Therapy.
CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery.
The Ex Vivo Production of IL-6 and IL-21 by CD4(+) T Cells is Directly Associated with Neurological Disability in Neuromyelitis Optica Patients.
The Sphingosine 1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Post-Infarction Left Ventricular Remodeling in a Porcine Model of Ischemia-Reperfusion.
Case Studies: LAAM, Naltrexone, Clozapine, and Nicorette
Catastrophic brain relapse in seronegative NMO after a single dose of natalizumab.
Fingolimod-induced asthma deterioration in a patient with relapsing-remitting multiple sclerosis.
Long-Term Decrease in VLA-4 Expression and Functional Impairment of Dendritic Cells during Natalizumab Therapy in Patients with Multiple Sclerosis.
Multiple sclerosis in Pakistan: histocompatibility antigen composition and disability.
Callosal atrophy in multiple sclerosis is related to cognitive speed.
Purinergic receptor P2RY12-dependent microglial closure of the injured blood-brain barrier.
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43.
Multiple sclerosis and the spinal cord.
High and dysregulated secretion of epidermal growth factor from immune cells of patients with relapsing-remitting multiple sclerosis.

Pages